Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in Breast Cancer CellsSangita M. Baxi(Pfizer (United States)), Min-Jean Yin(Pfizer (United States))PLoS ONEOctober 31, 201210.1371/journal.pone.0048402Cited by 15SaveCiteExport RISWatch citationsRelated PapersmiR-122 Regulates Tumorigenesis in Hepatocellular Carcinoma by Targeting AKT3|PLoS ONE|2013|102miR-221 Promotes Tumorigenesis in Human Triple Negative Breast Cancer Cells|PLoS ONE|2013|93